Post by Medacta USA, Inc.

More than 20 years of clinical evidence. One commitment to advancing hip replacement. Backed by independent studies and long-term registry data, Medacta’s Hip portfolio combines proven performance with continuous innovation. From primary to revision procedures, surgeons have access to comprehensive solutions designed to address a wide range of clinical challenges while supporting personalized care, reproducible outcomes, and enhanced recovery. Learn more about Medacta’s Hip solutions: https://lnkd.in/eZeriVm8 #Medacta #HipReplacement #TotalHipArthroplasty #THA #Orthopedics #JointReplacement #PersonalizedMedicine